Psychedelic Stock Gainers And Losers From May 20, 2022
GAINERS:
Mind Medicine (NASDAQ:MNMD) shares closed up 8.33% at $0.77
Upcoming U.S. FDA Decision A Potentially Major De-Risk Event For Revive Therapeutics
It’s been a long and arduous road for Revive Therapeutics Ltd. (OTC: RVVTF) regarding their Phase 3 clinical trial to evaluate the safety and efficacy of Bucillamine to treat COVID-19.
Cybin, Allied Among Top Psychedelic Movers Of Today
GAINERS:
Cybin (AMEX:CYBN) shares closed up 13.43% at $0.55
Intelgenx Technologies, Cybin Among Top Psychedelic Movers Of Today
GAINERS:
Intelgenx Technologies (OTC:IGXT) shares closed up 16.85% at $0.32
Allied, ATAI Life Sciences Among Top Psychedelic Movers Of Today
GAINERS:
Allied (OTC:ALID) shares closed up 5.27% at $0.76
Psyched: Elon Musk Praises Psychedelics Over Antidepressants, Field Trip To Split In Two, Colorado MDMA Bill Moves Forward
The world’s richest man gave another public nod to psychedelics medicine in favor of traditional mental health solutions.
Details Of Revive Therapeutics’ Update On Bucillamine Phase 3 Trial For COVID Treatment
Revive Therapeutics (OTC: RVVTF) has provided an update on Phase 3 of its Buc
ATAI Life Sciences, Compass Pathways Among Top Psychedelic Movers Of Today
GAINERS:
ATAI Life Sciences (NASDAQ:ATAI) shares closed up 3.97% at $4.97
Field Trip Health, Mind Medicine Among Top Psychedelic Movers Of Today
GAINERS:
Mind Medicine (NASDAQ:MNMD) shares closed up 3.49% at $0.87
Revive Therapeutics, Allied Among Top Psychedelic Movers Of Today
GAINERS:
Revive Therapeutics (OTC:RVVTF) shares closed up 19.57% at $0.33